Edition:
United States

Rocket Pharmaceuticals Inc (RCKT.OQ)

RCKT.OQ on NASDAQ Stock Exchange Global Market

20.49USD
25 May 2018
Change (% chg)

$0.04 (+0.20%)
Prev Close
$20.45
Open
$20.53
Day's High
$20.68
Day's Low
$20.28
Volume
49,552
Avg. Vol
94,284
52-wk High
$22.40
52-wk Low
$3.40

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.425
FY 2017 Dec '17 0.00 -0.716
Sep '17 0.00 -1.094
Jun '17 0.00 -0.972
Mar '17 0.00 -0.394
FY 2016 Dec '16 0.00 -1.925
Sep '16 0.00 -1.653
Jun '16 0.00 -1.305
Mar '16 0.00 -1.524
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 2 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 2 0.00 0.00 0.00 10.00
Year Ending Dec-18 2 0.00 0.00 0.00 6.67
Year Ending Dec-19 2 0.00 0.00 0.00 13.67
Earnings (per share)
Quarter Ending Jun-18 2 -0.34 -0.29 -0.38 -1.96
Quarter Ending Sep-18 2 -0.35 -0.31 -0.40 0.88
Year Ending Dec-18 2 -1.49 -1.35 -1.62 -5.64
Year Ending Dec-19 2 -1.73 -1.45 -2.00 -7.54
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 238.69 33.30
P/E High - Last 5 Yrs. -- 290.32 47.06
P/E Low - Last 5 Yrs. -- 99.28 24.86
Beta -- 0.74 0.78
Price to Sales (TTM) -- 247.63 8.09
Price to Book (MRQ) 4.75 24.09 4.47
Price to Tangible Book (MRQ) 5.81 27.23 5.99
Price to Cash Flow (TTM) -- 136.35 22.28
% Owned Institutions 80.71 10.88 2.37

Dividends

  Company industry sector
Dividend Yield -- 0.30 1.62
Dividend Yield - 5 Year Avg -- 0.20 0.77
Dividend 5 Year Growth Rate -- 2.28 3.80
Payout Ratio(TTM) -- 45.83 17.45

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 26.61 5.09
Sales (TTM) vs TTM 1 Yr. Ago -- 147.97 12.55
Sales - 5 Yr. Growth Rate -- 30.86 7.98
EPS (MRQ) vs Qtr. 1 Yr. Ago -7.74 -91.02 34.61
EPS (TTM) vs TTM 1 Yr. Ago 39.23 -- --
EPS - 5 Yr. Growth Rate -- 48.48 8.28
Capital Spending - 5 Yr. Growth Rate -- 40.00 8.10

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.63 2.56
Current Ratio (MRQ) 25.19 6.51 3.65
LT Debt to Equity (MRQ) 22.97 22.25 12.74
Total Debt to Equity (MRQ) 22.97 25.70 16.30
Interest Coverage (TTM) -33.15 -173.02 35.37

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.37 54.80
Gross Margin - 5 Yr. Avg. -- 54.86 52.64
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -152.51 15.90
Operating Margin (TTM) -- -867.63 0.55
Operating Margin - 5 Yr. Avg. -- -165.00 11.23
Pre-Tax Margin (TTM) -- -756.28 2.56
Pre-Tax Margin - 5 Yr. Avg. -- -169.57 11.46
Net Profit Margin (TTM) -- -748.18 -0.89
Net Profit Margin - 5 Yr. Avg. -- -168.96 7.75
Effective Tax Rate (TTM) -- 14.67 31.22
Effective Tax Rate - 5 Yr. Avg. -- 19.46 24.28

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,075,134 745,954,659
Net Income/Employee (TTM) -1,708,500 -795,133 86,895,337
Receivable Turnover (TTM) -- 17.26 5.95
Inventory Turnover (TTM) -- 2.45 3.58
Asset Turnover (TTM) 0.00 0.42 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -20.39 -5.32 10.30
Return on Assets - 5 Yr. Avg. -57.87 -0.30 11.20
Return on Investment (TTM) -21.19 -7.54 13.04
Return on Investment - 5 Yr. Avg. -63.92 2.97 14.50
Return on Equity (TTM) -29.28 -10.33 14.90
Return on Equity - 5 Yr. Avg. -260.73 -2.83 15.82
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 32.00 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Rocket Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 80.72%
# of Holders: 74
Total Shares Held: 31,869,295
3 Mo. Net Change: 27,899,812
# New Positions: 40
# Closed Positions: 17
# Increased Positions: 57
# Reduced Positions: 19
# Net Buyers: 38
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.